A standard physical may tell you that your laboratory results fall within the reference range. It may not tell you whether your cardiovascular risk is increasing, your metabolic health is deteriorating, or a correctable issue is contributing to fatigue, poor recovery, weight gain, or declining performance.
That does not mean everyone over 40 needs dozens of specialty tests.
The goal of advanced blood work should be to identify biomarkers that can change a decision. That decision might involve nutrition, exercise, medication, hormone therapy, further testing, or closer monitoring.
More data is not automatically better. Actionable data is better.
What Makes a Biomarker Actionable?
An actionable biomarker should answer at least one practical question:
- Does this result meaningfully change a person’s risk assessment?
- Could it identify a treatable condition?
- Will it influence a nutrition, exercise, medication, or lifestyle plan?
- Can it help monitor whether an intervention is working?
- Would an abnormal result justify additional evaluation?
A number without context can create anxiety without improving health. A useful result connects the laboratory value to symptoms, medical history, family history, medications, body composition, and long-term risk.
This distinction becomes especially important after 40, when changes in glucose regulation, cholesterol, blood pressure, kidney function, liver health, muscle mass, and hormone status may begin to overlap.
The Foundational Blood Tests Most Adults Still Need
Advanced testing should not replace basic laboratory work. In many cases, the standard tests provide the first clues that determine whether more specialized testing is appropriate.
Complete Blood Count
A complete blood count, or CBC, measures red blood cells, hemoglobin, hematocrit, white blood cells, and platelets.
It may help identify patterns associated with:
- Anemia
- Infection or inflammation
- Abnormal bleeding or clotting
- Nutrient deficiencies
- Medication effects
- Excessive red blood cell production during testosterone therapy
The CBC becomes especially relevant when someone reports fatigue, shortness of breath, reduced exercise tolerance, frequent illness, heavy menstrual bleeding, or unexplained bruising.
No single CBC value should be interpreted alone. Hydration, altitude, illness, medications, and hormone treatment can all affect the results.
Comprehensive Metabolic Panel
A comprehensive metabolic panel, or CMP, provides information about glucose, electrolytes, kidney function, liver enzymes, and blood proteins.
Important markers may include:
- Glucose
- Creatinine
- Estimated glomerular filtration rate, or eGFR
- Sodium and potassium
- Calcium
- Albumin
- Aspartate aminotransferase, or AST
- Alanine aminotransferase, or ALT
- Alkaline phosphatase
- Bilirubin
These values can uncover issues that affect medication selection, supplement safety, metabolic health, hydration, and recovery.
A normal CMP does not rule out every kidney or liver condition, but it provides an essential starting point.
Hemoglobin A1c and Fasting Glucose
Fasting glucose offers a snapshot of blood sugar at the time of the test. Hemoglobin A1c estimates average glucose exposure over approximately two to three months.
The American Diabetes Association recommends beginning routine diabetes screening by age 35 for most adults. People with prediabetes should generally be tested yearly, while people with normal results may be retested at least every three years, depending on their risk factors.
Common diagnostic reference points include:
- Hemoglobin A1c below 5.7%: generally considered below the prediabetes range
- Hemoglobin A1c from 5.7% to 6.4%: prediabetes range
- Hemoglobin A1c of 6.5% or higher: diabetes range when appropriately confirmed
- Fasting glucose from 100 to 125 mg/dL: impaired fasting glucose range
- Fasting glucose of 126 mg/dL or higher: diabetes range when appropriately confirmed
These numbers should be interpreted with context. Anemia, kidney disease, blood loss, pregnancy, certain medications, and differences in red blood cell turnover can affect A1c.
Someone may also have a normal fasting glucose while showing rising post-meal glucose or other early signs of metabolic dysfunction. That is why trends, waist circumference, triglycerides, blood pressure, activity, sleep, and family history still matter.
Advanced Cardiovascular Biomarkers After 40
Cardiovascular disease often develops silently. Advanced lipid testing can help clarify risk when a traditional cholesterol panel does not tell the full story.
Apolipoprotein B
Apolipoprotein B, commonly called ApoB, estimates the number of cholesterol-carrying particles capable of contributing to plaque formation.
Each atherogenic particle generally carries one ApoB molecule. This means ApoB can provide a clearer estimate of particle burden than low-density lipoprotein cholesterol, or LDL-C, alone.
ApoB can be particularly useful for people with:
- High triglycerides
- Insulin resistance
- Type 2 diabetes
- Metabolic syndrome
- Known cardiovascular disease
- Normal or moderately elevated LDL-C despite other risk factors
- Discordance between LDL-C and non-high-density lipoprotein cholesterol
The 2026 American College of Cardiology and American Heart Association dyslipidemia guideline recognizes ApoB as a useful tool for assessing residual cardiovascular risk, particularly in people with diabetes, elevated triglycerides, cardiovascular-kidney-metabolic conditions, or established cardiovascular disease.
An ApoB result is most useful when it changes the intensity of nutrition, exercise, medication, or risk-reduction strategies.
Lipoprotein(a)
Lipoprotein(a), abbreviated Lp(a), is an inherited lipoprotein associated with atherosclerotic cardiovascular disease and aortic valve disease.
Unlike many cholesterol markers, Lp(a) is largely determined by genetics and usually remains relatively stable. Diet and exercise may improve overall cardiovascular health without substantially lowering an inherited Lp(a) level.
The 2026 cardiovascular guidelines recommend that every adult have Lp(a) measured at least once. A level of 125 nmol/L or 50 mg/dL and above is generally considered elevated, although laboratories may report different units.
Testing is especially valuable for people with:
- A family history of premature heart disease
- A personal history of heart attack or stroke without clear risk factors
- Familial hypercholesterolemia
- Cardiovascular disease despite controlled LDL-C
- A family member with elevated Lp(a)
An elevated result may support earlier or more aggressive control of modifiable risks such as LDL-C, ApoB, blood pressure, glucose, smoking, body composition, and physical inactivity.
Non-HDL Cholesterol
Non-HDL cholesterol is calculated by subtracting HDL cholesterol from total cholesterol.
It represents the cholesterol carried by potentially atherogenic particles, including LDL, very-low-density lipoproteins, remnants, and Lp(a).
Because it is available from a standard lipid panel, non-HDL cholesterol is a practical and underused marker. It can be particularly useful when triglycerides are elevated.
High-Sensitivity C-Reactive Protein
High-sensitivity C-reactive protein, or hs-CRP, measures a protein that may rise in response to systemic inflammation.
It can sometimes help refine cardiovascular risk, but it is not specific to heart disease. Infection, injury, poor sleep, intense exercise, autoimmune conditions, obesity, and other sources of inflammation can raise it.
An isolated elevated result should not automatically trigger treatment. It may need to be repeated when the person is healthy and has avoided unusually intense exercise.
The test becomes actionable when it supports a broader evaluation of cardiovascular and inflammatory risk rather than being treated as a diagnosis by itself.
Metabolic Biomarkers Beyond A1c
Weight, glucose, insulin, triglycerides, liver health, sleep, and muscle mass are connected. After 40, evaluating these systems together may reveal more than reviewing each result in isolation.
Fasting Insulin
Fasting insulin may provide additional context when someone has signs of insulin resistance despite a normal or borderline glucose result.
It may be considered when there is:
- Central weight gain
- Elevated triglycerides
- Low HDL cholesterol
- Polycystic ovary syndrome
- Prediabetes
- A strong family history of type 2 diabetes
- Difficulty losing weight despite a structured plan
However, fasting insulin does not have a universally accepted diagnostic cutoff. Insulin assays are not fully standardized across laboratories, which limits the use of a single “optimal” range.
That does not make the test useless. It means fasting insulin should be interpreted as one part of a metabolic pattern rather than used to diagnose insulin resistance by itself.
Triglyceride-to-HDL Ratio
The triglyceride-to-HDL ratio may offer a simple clue about metabolic health, but it is not a standalone diagnostic test.
A rising ratio may appear alongside:
- Insulin resistance
- Visceral fat gain
- Low physical activity
- Poor dietary quality
- Excess alcohol intake
- Genetic lipid disorders
The ratio should lead to a closer look at the full picture rather than a rigid universal target.
Continuous Glucose Monitoring
A continuous glucose monitor is not a blood biomarker panel, but short-term monitoring may provide useful information in selected individuals.
It can reveal:
- Post-meal glucose patterns
- Overnight glucose changes
- Responses to specific meals
- Effects of walking, sleep, stress, and exercise
- Glucose variability not captured by fasting glucose
Continuous glucose data can become noise when people react to every minor change. Its best use is identifying repeatable patterns that lead to a clear behavioral or medical decision.
Kidney Biomarkers That Are Easy to Miss
Creatinine and eGFR are commonly included in routine laboratory panels. They do not provide the entire picture of kidney health.
Estimated Glomerular Filtration Rate
Estimated glomerular filtration rate uses creatinine and other variables to estimate how well the kidneys filter blood.
One abnormal eGFR result does not necessarily indicate chronic kidney disease. Hydration, muscle mass, creatine use, illness, age, and medications can affect creatinine-based estimates.
Persistent changes are more meaningful than an isolated result.
Urine Albumin-to-Creatinine Ratio
A urine albumin-to-creatinine ratio, or uACR, checks for small amounts of albumin leaking into the urine.
This may reveal kidney or vascular damage before a significant decline in eGFR appears. It is particularly relevant for people with:
- Diabetes
- High blood pressure
- Cardiovascular disease
- A family history of kidney disease
- Obesity
- Abnormal kidney results
Kidney Disease: Improving Global Outcomes recommends using both glomerular filtration and albuminuria when evaluating and classifying chronic kidney disease.
This is a useful example of an inexpensive test that may be more actionable than many heavily marketed specialty panels.
Liver Health and Metabolic Dysfunction
Liver enzymes may be normal even when metabolic dysfunction-associated steatotic liver disease is present.
Relevant blood markers include:
- ALT
- AST
- Gamma-glutamyl transferase, or GGT
- Platelet count
- Triglycerides
- Glucose
- Hemoglobin A1c
FIB-4 Score
The fibrosis-4 index, or FIB-4, uses age, AST, ALT, and platelet count to estimate the likelihood of advanced liver fibrosis.
It does not diagnose liver disease. It helps determine who may benefit from additional testing, such as liver imaging or elastography.
The American Association for the Study of Liver Diseases recommends FIB-4 as an initial risk-assessment tool for appropriate patients with metabolic risk or suspected fatty liver disease.
FIB-4 may be especially relevant after 40 because age is part of the calculation and metabolic risk often increases during midlife.
Thyroid Testing After 40
Fatigue, weight changes, constipation, anxiety, hair thinning, temperature sensitivity, menstrual changes, and poor concentration can overlap with thyroid dysfunction.
They can also result from sleep loss, inadequate nutrition, iron deficiency, medication effects, depression, menopause, metabolic dysfunction, and many other causes.
Thyroid-Stimulating Hormone
Thyroid-stimulating hormone, or TSH, is typically the first laboratory test used to evaluate thyroid function.
When TSH is persistently abnormal, free thyroxine, or free T4, may help distinguish between different types of thyroid dysfunction. The U.S. Preventive Services Task Force states that evidence remains insufficient to recommend universal thyroid screening for every asymptomatic, nonpregnant adult.
This means thyroid testing should be guided by symptoms, medical history, family history, medications, physical findings, pregnancy considerations, and previous thyroid disease.
Thyroid Antibodies
Thyroid peroxidase antibodies and thyroglobulin antibodies may help evaluate suspected autoimmune thyroid disease.
They are not necessarily useful as frequently repeated monitoring markers. Once autoimmune thyroid disease is established, treatment decisions are generally driven more by thyroid function, symptoms, examination, and clinical context than by repeatedly chasing antibody fluctuations.
Reverse T3
Reverse T3 is frequently included in commercial “advanced thyroid” panels.
It has limited routine clinical value for diagnosing hypothyroidism in most outpatient settings. It may be appropriate in narrow clinical situations, but it should not replace TSH, free T4, medical history, and a complete evaluation.
A test is not automatically valuable because it sounds more sophisticated.
Hormone Biomarkers for Men After 40
Hormone testing should begin with symptoms and a clinical question, not an assumption that age alone requires treatment.
Possible symptoms of testosterone deficiency include:
- Reduced libido
- Fewer spontaneous erections
- Loss of strength or muscle
- Reduced bone density
- Persistent fatigue
- Fertility concerns
- Unexplained anemia
Total Testosterone
For men with relevant symptoms, total testosterone should generally be measured in the morning using a reliable assay.
A single low result is not enough to establish testosterone deficiency. The Endocrine Society recommends diagnosing hypogonadism only when compatible symptoms occur alongside consistently low testosterone concentrations. A low morning result should be confirmed on a separate morning.
Free Testosterone and Sex Hormone-Binding Globulin
Free testosterone and sex hormone-binding globulin, or SHBG, may be useful when total testosterone is borderline or when a condition may alter SHBG.
SHBG can be affected by factors such as:
- Body composition
- Insulin resistance
- Thyroid status
- Liver function
- Aging
- Certain medications
Luteinizing hormone, follicle-stimulating hormone, prolactin, and other tests may then help determine why testosterone is low.
The purpose is not merely to find a low number. It is to identify the cause and select an appropriate treatment.
Hormone Biomarkers for Women After 40
Hormone evaluation during perimenopause requires a different approach.
Estradiol, progesterone, and follicle-stimulating hormone can fluctuate considerably during the menopausal transition. One result may not represent the broader monthly pattern.
For many women over 45, perimenopause is evaluated primarily through age, menstrual changes, symptoms, medical history, and the exclusion of other conditions. There is no single laboratory test that reliably identifies every stage of perimenopause.
Targeted hormone testing may still be appropriate when evaluating:
- Symptoms before age 40
- Possible premature ovarian insufficiency
- Fertility concerns
- Absent or highly irregular periods
- Abnormal uterine bleeding
- Hyperandrogen symptoms
- Pituitary concerns
- Treatment monitoring
- Symptoms that do not fit a typical menopausal pattern
For women with fatigue, weight changes, hair loss, poor sleep, or mood changes, the most actionable laboratory findings may sometimes come from thyroid, iron, glucose, lipid, or blood-count testing rather than a large reproductive hormone panel.
Nutrient Biomarkers for Fatigue and Performance
Nutrient testing is most useful when symptoms, dietary patterns, medications, or medical history suggest a realistic risk of deficiency.
Ferritin and Iron Studies
Ferritin reflects stored iron, although inflammation can raise ferritin and complicate interpretation.
A complete iron evaluation may include:
- Ferritin
- Serum iron
- Total iron-binding capacity
- Transferrin saturation
- CBC
Iron testing may be particularly relevant for people with:
- Heavy menstrual bleeding
- Gastrointestinal symptoms
- A restrictive diet
- Frequent blood donation
- Reduced exercise capacity
- Restless legs
- Hair shedding
- Unexplained fatigue
Low ferritin should lead to a search for the cause rather than automatic long-term iron supplementation.
Vitamin B12 and Folate
Vitamin B12 testing may be useful for people with:
- Vegan or vegetarian diets
- Metformin use
- Long-term acid-suppressing medication use
- Gastrointestinal disease or surgery
- Numbness or tingling
- Macrocytic anemia
- Memory or balance concerns
A borderline result may require additional testing, such as methylmalonic acid, depending on the clinical situation.
Vitamin D
Vitamin D affects bone and mineral health, but universal screening of every healthy adult remains debated.
Testing is more likely to be actionable when someone has:
- Osteoporosis or low bone density
- Recurrent fractures
- Malabsorption
- Limited sun exposure
- Certain kidney, liver, or parathyroid conditions
- Medications that affect bone metabolism
- A previous deficiency
Very high supplement doses should not be used simply to chase an arbitrary “optimal” number.
Biomarkers That May Be Useful in Selected Cases
The following tests can offer value when ordered for a specific reason:
- Homocysteine
- Uric acid
- Cystatin C
- GGT
- Magnesium
- Cortisol
- DHEA sulfate
- Prolactin
- Insulin-like growth factor 1
- Creatine kinase
- Celiac antibodies
- Autoimmune markers
They should not automatically be included in every panel.
For example, a random cortisol result rarely explains general stress or fatigue by itself. Autoimmune panels can create false alarms when ordered without compatible symptoms. Creatine kinase may rise after hard training without indicating disease.
The question should always be: What will we do differently based on this result?
A Practical Tiered Blood Work Strategy After 40
A useful blood work plan can be organized into three levels.
Level 1: Foundational Health Assessment
Depending on personal risk and medical history, a foundational assessment may include:
- CBC
- CMP
- Fasting glucose
- Hemoglobin A1c
- Standard lipid panel
- Blood pressure
- Waist circumference
- Weight and body-composition trends
TSH, ferritin, vitamin B12, and other tests may be added when symptoms or risk factors justify them.
Level 2: Cardiometabolic Risk Clarification
Additional testing may include:
- ApoB
- Lp(a)
- Non-HDL cholesterol
- hs-CRP
- Fasting insulin
- uACR
- GGT
- FIB-4 calculation
This level may be appropriate for someone with metabolic risk, a strong family history, abnormal foundational results, or uncertainty about cardiovascular risk.
Level 3: Symptom- or Treatment-Specific Testing
This level may include:
- Free T4 and thyroid antibodies
- Total and free testosterone
- SHBG
- Estradiol or progesterone when clinically appropriate
- Luteinizing hormone and follicle-stimulating hormone
- Prolactin
- Iron studies
- Vitamin B12 with methylmalonic acid
- Cystatin C
- Specialty gastrointestinal or autoimmune testing
These tests should answer a defined clinical question or monitor a specific treatment.
How Often Should Advanced Blood Work Be Repeated?
Testing frequency depends on the result and what is being done about it.
Examples include:
- Lp(a): Often measured once because it is largely genetically determined.
- A1c: At least every three years when results and risk are normal, and more frequently with prediabetes, diabetes, medication changes, or increasing risk.
- Lipids and ApoB: Rechecked after a meaningful intervention or medication adjustment, then monitored according to cardiovascular risk.
- Kidney markers: Repeated more often with diabetes, hypertension, kidney disease, or medications that affect kidney function.
- Hormone markers: Repeated when confirming a diagnosis, adjusting treatment, or monitoring safety.
- CBC and liver markers: Monitored according to symptoms, medications, previous abnormalities, and treatment plans.
Repeating a stable test every few weeks rarely adds value. Testing should occur at an interval long enough for the intervention to produce a meaningful biological change.
How to Get More Reliable Laboratory Results
Consistency matters when comparing results over time.
Before testing, follow the instructions provided by your clinician and laboratory. Depending on the panel, that may include:
- Completing an appropriate fasting period
- Scheduling hormone testing at a consistent time
- Avoiding unusually intense exercise before the draw
- Avoiding excessive alcohol
- Reporting recent illness
- Reviewing medications and supplements
- Using the same laboratory when possible
- Maintaining normal hydration
Do not stop prescription medication or supplements unless your healthcare professional instructs you to do so.
A laboratory trend collected under similar conditions is usually more useful than comparing isolated results collected under completely different circumstances.
The Bottom Line
Advanced blood work after 40 can provide valuable information, but the most useful panel is not necessarily the largest one.
The strongest approach combines:
- Foundational laboratory testing
- Advanced cardiovascular risk markers
- Metabolic and organ-function assessment
- Symptom-driven hormone testing
- Targeted nutrient evaluation
- Personal and family history
- A plan for acting on the results
A biomarker becomes valuable when it leads to a better decision.
At 1st Optimal, advanced blood work is reviewed alongside your symptoms, goals, medical history, body composition, medications, nutrition, sleep, exercise, and long-term health risks. The purpose is not to generate a longer laboratory report. It is to build a personalized plan for improving health, performance, and longevity.
Explore personalized functional healthcare with 1st Optimal.
Frequently Asked Questions
What blood tests should every adult over 40 consider?
Many adults benefit from foundational testing that includes a CBC, CMP, fasting glucose, hemoglobin A1c, and lipid panel. Additional testing should depend on symptoms, cardiovascular risk, medications, family history, and previous results.
Is ApoB more useful than LDL cholesterol?
ApoB can provide additional information because it estimates the number of atherogenic particles. It may be especially helpful when triglycerides are elevated, insulin resistance is present, or LDL-C does not appear to match the person’s overall risk.
Should everyone over 40 test lipoprotein(a)?
The 2026 cardiovascular guideline recommends measuring Lp(a) at least once in adulthood. Because it is largely inherited and stable, it may not need frequent retesting.
Do women need hormone testing to diagnose perimenopause?
Not always. For many women over 45, perimenopause is evaluated through symptoms, menstrual history, age, and medical history. Hormone levels fluctuate and may not accurately represent the overall transition from a single blood draw.
Should men have testosterone checked after 40?
Men with symptoms consistent with testosterone deficiency may benefit from testing. Diagnosis should not be based on age or a single result. Low testosterone should generally be confirmed with a second morning measurement.
Is fasting insulin an important test?
It can provide useful context in selected people with metabolic risk. However, fasting insulin assays lack universal standardization, so the result should not be used alone to diagnose insulin resistance.
Are “normal” laboratory results always optimal?
No. A reference range describes values found across a laboratory population. It does not automatically account for symptoms, personal risk, treatment goals, or changes over time. At the same time, a result outside a self-described “optimal” range does not automatically indicate disease.
Medical disclaimer: This article is educational only and is not medical advice. Laboratory testing and treatment decisions should be personalized with a qualified healthcare professional.
